Israel Englander Inmune Bio, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 241,248 shares of INMB stock, worth $583,820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241,248
Previous 291,327
17.19%
Holding current value
$583,820
Previous $1.36 Million
38.53%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INMB
# of Institutions
92Shares Held
6.98MCall Options Held
317KPut Options Held
1.81M-
Praetorian Pr LLC Rincon, PR865KShares$2.09 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$943,6330.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...